Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study

Jacob P. Laubach, Fredrik Schjesvold, Mário Mariz, Meletios Α. Dimopoulos, Ewa Lech‐Marańda, Ivan Špıčka, Vânia Hungria, Tatiana Shelekhova, André Abdo, Lutz Jacobasch, Chantana Polprasert, Roman Hájek, Árpád Illés, Tomasz Wróbel, Anna Sureda, Meral Beksaç, Iara Gonçalves, Joan Bladé, S. Vincent Rajkumar, Ajai Chari, Sagar Lonial, Andrew Spencer, Pierre Maison‐Blanche, Philippe Moreau, Jesús F. San Miguel, Paul G. Richardson